National Meeting Highlights from the American Academy of Pain Management Meeting 2013
Release Date: November 11, 2013
Expiration Date: November 11, 2014
Expected time to complete this activity as designed: 60 minutes
There are no fees for participating in or receiving credit for this online activity.
This educational initiative offers highlights from key sessions presented at American Academy of Pain Management Meeting in September 2013. Experts in the field of pain management offer clinical perspectives on the challenges facing pain practitioners today.
This activity is designed for pain management specialists, oncologists, primary care specialists, nurses, nurse practitioners, and pharmacists who provide care to patients with chronic pain.
Upon completion of this educational activity, participants should be able to:
- Identify and interpret therapeutic implications of new data presented at the 2013 American Academy of Pain Management national conference related to safe and effective management of chronic pain patients
- Translate current guidelines and recent data regarding safety and efficacy of current and novel approaches to chronic pain
Gain Control of Pain: An Interprofessional Model – Paul Arnstein, RN, PhD, FAAN
Pharmacist Role in Pain Management − David S. Craig, PharmD
Interfacing with the Safety Net: Pain Management in the Emergency Room − Marla Golden, DO
Quality Improvement for Opioid Pain Management: Practical Steps You Can Use Next Week – Jeffrey A. Gudin, MD
Finding Black Ducks: Five Psychosocial Treatments to Empower Patients with Chronic Pain Syndrome – Bruce F. Singer, PsyD
Instructions for Participation and Credit
This activity is eligible for credit through November 11, 2014. After this date, this activity will expire and no further credit will be awarded.
1. Read the target audience, learning objectives, and faculty disclosures.
2. You may be asked to complete a short pre-test before accessing the educational content. This must be completed in order to move forward in the activity.
3. Complete the educational content as designed.
4. Complete the post-test. To receive a certificate, you must receive a passing score of 70%.
5. Complete the activity evaluation survey to provide feedback and information useful for future programming.
6. Certificates may be printed immediately after successfully completing the post-test and activity evaluation.
Michael J. Brennan, MD
The Pain Center of Fairfield
Associate Director, Chronic Pain and Recovery Center
Silver Hill Hospital
New Canaan, Connecticut
Dr. Michael J. Brennan received his medical degree at the State University of New York Downstate Medical Center, and completed a residency in physical medicine and rehabilitation at the New York Hospital-Cornell University Medical Center, where he served as chief resident. While at New York Hospital, Dr. Brennan also served as chief resident at the International Center for the Disabled in New York City. Dr. Brennan is a board certified physiatrist in private practice in Fairfield, Connecticut.
After completing his residency, Dr. Brennan was appointed to the faculty of New York Hospital and Cornell Medical College in the Department of Physical Medicine and Rehabilitation. He served as acting chief of the rehabilitation service in the Department of Neurology at Memorial Sloan-Kettering Cancer Center. After leaving Sloan-Kettering, Dr. Brennan became the medical director of the Rehabilitation Center of Fairfield County and Ahlbin Centers for Rehabilitation Medicine and chief of the section of physical medicine at Bridgeport Hospital in Bridgeport, Connecticut. He is currently a senior attending physician in the Department of Medicine at Bridgeport Hospital and consulting physician at St. Vincent’s Hospital in Bridgeport, Connecticut. He is associate director of the interdisciplinary chronic pain and addiction program at Silver Hill Hospital in New Canaan, Connecticut, which is designed to address the complex needs of patients suffering with chronic pain and substance misuse, addiction and behavioral disorders.
Dr. Brennan has special interests in the emerging role of pharmacogenomics, particularly as to the role of variability and vulnerability to opioid and adjuvant analgesics in individuals suffering with pain. He has recently published articles on opioids and pharmacogenomics opioid metabolism as well as articles concerning deleterious effects of opioids on the endocrine system. Dr. Brennan has a long-held interest in the management of pain as well as disability in patients suffering from the acute and long-term effects of musculoskeletal diseases, neurological disorders, cancer, and various cancer treatments. He has published over 40 scholarly articles, abstracts, and textbook chapters on the treatment of cancer and noncancer related disabilities including lymphedema and pain. He is a reviewer for several medical journals and has served as guest editor for the Journal of Musculoskeletal Rehabilitation and as online editor for Pain.com. Recently, Dr. Brennan was awarded the Dr. Elizabeth Narcessian Memorial Award from Kessler Institute, recognizing his commitment to the treatment of patients suffering from chronic pain.
Paul Arnstein, RN, PhD, FAAN
Clinical Nurse Specialist for Pain Relief
Massachusetts General Hospital
Dr. Paul Arnstein earned a doctorate in nursing from Boston College in Chestnut Hill, Massachusetts and completed research training fellowships from the National Institutes of Health. For over 30 years, he has helped thousands of patients in pain. His work with patients, professionals, and policymakers is driven by a desire to ensure that no patient lives or dies with needless pain due to unrealistic fears and mistaken beliefs about pain and its treatment. His research has been referenced in the popular media and supports the value of nurse-led interventions that help chronic pain patients think, feel, and do better.
Dr. Arnstein was a founder and first president of the New Hampshire Cancer Pain Initiative and has served as president of the New England Pain Association and the American Society for Pain Management Nursing (ASPMN). He presided over ASPMN at a time when pain management nursing emerged as a specialty within nursing. Dr. Arnstein helped develop the core curricula, exam, and certification preparation materials that have benefited over 1,000 nurses and the patients they serve. As a liaison to the Joint Commission, and an advisor to legislators through the Pain Care Forum, Dr. Arnstein has expanded nursing’s influence in promoting access to pain relievers and ensuring their safe use.
Dr. Arnstein has participated in the development and dissemination of several position papers to help reduce pain in vulnerable populations. He is a strong spokesperson for nursing’s contributions for interdisciplinary programs and clinical guidelines developed by the American Pain Society, American Pain Foundation, and the Agency for Healthcare Research and Quality. Dr. Arnstein is widely published and frequently speaks at local, regional, and national levels addressing topics that help improve the way pain is managed.
David S. Craig, PharmD
Pain Management and Palliative Care Services|
Moffitt Cancer Center and Research Institute
Dr. David Craig received his doctor of pharmacy degree from the University of Tennessee. He then completed a residency at Duke University Hospital and a pain management/palliative care specialty residency at the Moffitt Cancer Center. Recently, he completed a Mayday Pain & Society fellowship, which trains physicians, nurses, pharmacists, social workers, and legal scholars to more effectively communicate their work and raise awareness for people with acute or chronic pain. Dr. Craig is currently a pharmacist lead for the Pain Management and Palliative Care Services at the Moffitt Cancer Center and Research Institute in Tampa, Florida. He is currently serving in various leadership roles within the American Pain Society, American Society of Health-System Pharmacists, and has held similar positions within the American College of Clinical Pharmacy. In addition, he has served as a consultant and in 2010 was appointed to the Florida Prescription Drug Monitoring Program Oversight Task Force by Florida Governor Charlie Crist.
Marla Golden, DO
Integrative Pain Management
Dr. Marla Golden graduated from the Philadelphia College of Osteopathic Medicine and completed her residency in emergency medicine at the University of Florida Health Science Center, Jacksonville, Florida. Dr. Golden practiced emergency medicine in Florida and served as the medical director of the Emergency Department at HCA Putnam Community Hospital and as the medical director of EMS in Putnam County. She transitioned her practice to pain medicine in 1998, establishing the solo practice of Integrative Pain Management in 2000. In addition, Dr. Golden is the co-founder of Neuroplastix, a company dedicated to the promotion of neuroplastic treatment for persistent pain.
Dr. Golden is a fellow of the American College of Emergency Physicians and is a diplomate of both the American Board of Emergency Medicine and the American Board of Pain Medicine. She has served as the chair of the Credentials Committee of the American Board of Pain Medicine, as a member of the Examination Council, and has served on the Annual Meeting Planning Committee of the American Academy of Pain Medicine. She has been active in Florida as a spokesperson for the Florida Academy of Pain Medicine, and served on the Board of Directors and as the Legislative Chair and Public Relations Chair.
Dr. Golden practices a holistic and comprehensive approach to treating patients in pain. Her practice includes an emphasis on osteopathic structural assessment and optimization techniques. For many years, she has utilized manual therapy in combination with medication management and minimally invasive interventional techniques. Her interest in connective tissue grew while studying craniosacral therapy and a variety of other manual therapy techniques including shiatsu, structural integration, fascial manipulation, acutonics, and acupuncture theory. This led to the development of her hybrid technique, fascial body manipulation. She now continues this work within the larger framework of neuroplastic transformation, a groundbreaking treatment approach that establishes brain neuroplasticity and the interplay with the neuroimmune system as the core concepts used to treat persistent pain. Dr. Golden lectures nationally on neuroplastic transformation and recently co-authored the Neuroplastic Transformation Workbook designed to teach practitioners how to use neuroplastic treatment approaches and provide patients with a written guide to recover from persistent pain disorders.
Jeffrey A. Gudin, MD
Pain Management Center
Englewood Hospital and Medical Center
Englewood, New Jersey
Dr. Jeffrey A. Gudin received his medical degree from Albany Medical College in Albany, New York. Following a transitional internship in surgery, medicine, and anesthesiology at St. Barnabas Medical Center in Livingston, New Jersey, he completed a residency in anesthesiology at Yale University School of Medicine. He continued his training with an extended postdoctoral fellowship in pain medicine at the Yale Center for Pain Management, where he was actively involved in research and teaching. He is currently director of the Pain Management Center at Englewood Hospital and Medical Center in New Jersey, an affiliate of the Mount Sinai School of Medicine. Dr. Gudin is board certified in pain medicine and anesthesiology, and is board eligible in addiction medicine.
An active speaker in the field of pain management, Dr. Gudin has been interviewed on various television news channels, including CBS, and other national news networks. Dr. Gudin has also been quoted in The New York Times and various regional newspapers in New Jersey and Connecticut. His clinical and research focus includes pain management, regional anesthesia, and preemptive analgesia, as well as increasing clinician awareness of pain assessment and management.
Bruce F. Singer, PsyD
Director of the Chronic Pain and Recovery Center
Silver Hill Hospital
New Canaan, Connecticut
Dr. Bruce Singer earned both his masters and doctor of psychology degrees from Pepperdine University’s Graduate School of Education and Psychology in Los Angeles, California, and is licensed as a psychologist in Connecticut, New York, and California. He is the founding director of the Chronic Pain and Recovery Center (CPRC) at Silver Hill Hospital in New Canaan, Connecticut. The CPRC is a residential interdisciplinary program for the treatment of chronic pain and co-occurring disorders. In addition to his clinical work, Dr. Singer has published articles and book chapters on mindfulness approaches to the treatment of substance abuse and chronic pain.
Accreditation Statement: MediCom Worldwide, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Designation Statement: MediCom Worldwide, Inc. designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
MediCom Worldwide, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is acceptable for 1.0 contact hour of Continuing Education Credit. Universal Activity Number: 827-0000-13-375-H01-P. Knowledge-based CPE activity.
In order for CPE Monitor to authenticate credit, pharmacists/technicians must provide their e-Profile ID number from NABP and date of birth (in MMDD format) when registering for a CPE program. Please make sure to provide this information in your Member Profile accessed through the Member Center on the home page of this site.
Accreditation Statement: MediCom Worldwide, Inc., 101 Washington Street, Morrisville, PA 19067 is approved by the California Board of Registered Nursing, Provider Number CEP11380. MediCom designates this CNE activity for 1.0 contact hour. Program Number: 13-375-337
As an organization accredited by the Accreditation Council for Continuing Medical Education (ACCME), Accreditation Council for Pharmacy Education (ACPE) and California State Board of Registered Nursing, MediCom Worldwide, Inc. requires everyone who is a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest. Accordingly, the following disclosures were made.
Dr. Michael Brennan has received honoraria related to speakers' bureau activities and as a consultant from Covidien; Endo Pharmaceuticals Inc.; Insys Therapeutics, Inc.; Millennium Laboratories, LLC; Purdue Pharma L.P.; Teva Pharmaceuticals; and Zogenix, Inc., as well as speakers’ bureau activities from Johnson & Johnson Services, Inc.
Drs. Paul Arnstein, David Craig, and Bruce Singer have disclosed no relevant financial relationships.
Dr. Marla Golden owns significant holdings in Neuroplastic Partners, LLC.
Dr. Jeffrey Gudin has received consultant fees from Insys Therapeutics, Inc., Mallinckrodt Inc. (now Covidien), Nektar, and Purdue Pharma L.P., as well as honoraria related to speakers’ bureau activities from Endo Pharmaceuticals Inc., Insys, Johnson & Johnson Services, Inc., Purdue, and Teva Pharmaceuticals. He has received grant support related to research activities from Nektar and Teva.
Planning Committee Disclosures
The individual listed below from MediCom Worldwide, Inc. reported the following for this activity: Joan Meyer, RN, MHA, executive director, has no relevant financial relationships.
Peer Reviewer Disclosure
In accordance with MediCom Worldwide, Inc. policy, all content is independently peer reviewed for balance, objectivity and commercial bias. The peer reviewers have no relevant financial relationships to disclose.
Off-Label Disclosures/Investigational Disclosures
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees/participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.
Drs. Brennan, Craig, Golden, Gudin, and Singer have indicated that they do not intend to discuss off-label uses of drugs, mechanical devices, biologics or diagnostics approved by the US Food and Drug Administration (FDA) for use in the US.
Dr. Arnstein has indicated that he does intend to discuss off-label uses of drugs, mechanical devices, biologics or diagnostics approved by the US Food and Drug Administration (FDA) for use in the US.
Drs. Arnstein, Brennan, Craig, Golden, Gudin, and Singer have indicated that they do not intend to discuss investigational drugs, mechanical devices, biologics or diagnostics not approved by the FDA for use in the US.
MediCom Worldwide, Inc. requires Internet Explorer® version 9.0 or higher, the latest version of Google Chrome, or the latest version of Safari, a computer running Windows® Vista, Windows® 7, or Mac OS X, 512MB of RAM or greater, 1.5 GHZ or faster processor, and a screen resolution of 1024x768 or higher. Certain educational activities may require additional software to view. These activities will be marked with the information and/or links to the required software. That software may include Adobe® Flash® Player, Adobe® Acrobat®, Windows Media® Player and/or Microsoft® Silverlight™.
If you have any questions or concerns regarding this activity, please contact MediCom Worldwide, Inc. at 1-800-408-4242 or email us at firstname.lastname@example.org.
Provided by MediCom Worldwide, Inc.
This activity is supported by educational grants from Purdue Pharma, L.P.
©2013 MediCom Worldwide, Inc., 101 Washington St., Morrisville, PA 19067, 800-408-4242.
No portion of this material may be copied or duplicated without the expressed permission of MediCom Worldwide, Inc.